Paper92180
Viral xenogenization of intact tumor cells.
Kobayashi H. Adv Cancer Res, 1979. Cited by 50 papers, by iCite.
Cite this record
ConductScience Library. Viral xenogenization of intact tumor cells. Papers, record 92180. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/92180
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antibodies, Neoplasm | Major topic |
| Antigens, Neoplasm | Major topic |
| Antigens, Viral | Major topic |
| Neoplasms, Experimental | Major topic |
| Animals | |
| Antibodies, Viral | |
| Epitopes | |
| Immunity | |
| Immunotherapy | |
| Mice | |
| Rats | |
| Virus Diseases |
Source PubMed
Cited by24
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 50 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 36366533 | Life after Cleavage: The Story of a β-Retroviral (MMTV) Signal Peptide-From Murine Lymphoma to Human Breast Cancer. | Viruses | 2022 | https://conductscience.org/library/papers/36366533 | PubMed |
| 34209981 | Combinatorial Approaches for Cancer Treatment Using Oncolytic Viruses: Projecting the Perspectives through Clinical Trials Outcomes. | Viruses | 2021 | https://conductscience.org/library/papers/34209981 | PubMed |
| 34209584 | Viral Control of Glioblastoma. | Viruses | 2021 | https://conductscience.org/library/papers/34209584 | PubMed |
| 33967605 | Advances in the Study of Antitumour Immunotherapy for Newcastle Disease Virus. | Int J Med Sci | 2021 | https://conductscience.org/library/papers/33967605 | PubMed |
| 32937446 | Xenogenization of tumor cells by fusogenic exosomes in tumor microenvironment ignites and propagates antitumor immunity. | Sci Adv | 2020 | https://conductscience.org/library/papers/32937446 | PubMed |
| 30767816 | Viral oncolytic immunotherapy in the war on cancer: Infection control considerations. | Infect Control Hosp Epidemiol | 2019 | https://conductscience.org/library/papers/30767816 | PubMed |
| 28536382 | Fifty Years of Clinical Application of Newcastle Disease Virus: Time to Celebrate! | Biomedicines | 2016 | https://conductscience.org/library/papers/28536382 | PubMed |
| 10341877 | Human tumor cell modification by virus infection: an efficient and safe way to produce cancer vaccine with pleiotropic immune stimulatory properties when using Newcastle disease virus. | Gene Ther | 1999 | https://conductscience.org/library/papers/10341877 | PubMed |
| 8294213 | Progression of a weakly tumorigenic mouse fibrosarcoma at the site of early phase of inflammation caused by plastic plates. | Jpn J Cancer Res | 1993 | https://conductscience.org/library/papers/8294213 | PubMed |
| 7642685 | Biotherapy of cancer. Perspectives of immunotherapy and gene therapy. | J Cancer Res Clin Oncol | 1995 | https://conductscience.org/library/papers/7642685 | PubMed |
| 6985248 | Antigenic variation in cancer metastasis: immune escape versus immune control. | Cancer Metastasis Rev | 1982 | https://conductscience.org/library/papers/6985248 | PubMed |
| 6607104 | Immune responses of DBA/2 mice bearing melanoma tumors: cell-mediated immune responses after challenge with vaccinia virus. | Cancer Immunol Immunother | 1983 | https://conductscience.org/library/papers/6607104 | PubMed |
| 6602203 | Protection against two spontaneous mouse leukemias conferred by immunogenic variants obtained by mutagenesis. | J Exp Med | 1983 | https://conductscience.org/library/papers/6602203 | PubMed |
| 6561067 | Immunogenic changes of murine lymphoma cells following in vitro treatment with aryl-triazene derivatives. | Cancer Immunol Immunother | 1984 | https://conductscience.org/library/papers/6561067 | PubMed |
| 6299231 | Susceptibility of Marek's disease lymphoblastoid cell lines to infection with influenza and pseudorabies viruses and the protective effect of immunization with influenza virus-infected lymphoblastoid cells. | Arch Virol | 1982 | https://conductscience.org/library/papers/6299231 | PubMed |
| 6203637 | Immune recognition of tumor cells in mice infected with Pichinde virus. | Cancer Immunol Immunother | 1984 | https://conductscience.org/library/papers/6203637 | PubMed |
| 3632916 | Development of highly immunogenic variants of a rat fibrosarcoma line during in vitro cultivation. | Cancer Immunol Immunother | 1986 | https://conductscience.org/library/papers/3632916 | PubMed |
| 3594972 | Prevention of metastatic spread by postoperative immunotherapy with virally modified autologous tumor cells. II. Establishment of specific systemic anti-tumor immunity. | Clin Exp Metastasis | 1987 | https://conductscience.org/library/papers/3594972 | PubMed |
| 3359458 | Characteristics of reovirus-mediated chemoimmunotherapy of murine L1210 leukemia. | Cancer Immunol Immunother | 1988 | https://conductscience.org/library/papers/3359458 | PubMed |
| 3297373 | Chemical xenogenization of experimental tumors. | Cancer Metastasis Rev | 1987 | https://conductscience.org/library/papers/3297373 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/92180
GET https://conductscience.org/api/papers/v1/92180/cited_by?page=2